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Noonan syndrome and related disorders are caused by mutations in genes encoding for
proteins of the RAS-ERK1/2 signaling pathway, which affect development by enhanced
ERK1/2 activity. However, the mutations’ effects throughout adult life are unclear. In
this study, we identify that the protein most commonly affected in Noonan syndrome,
the phosphatase SHP2, known in Drosophila as corkscrew (CSW), controls life span,
triglyceride levels, and metabolism without affecting ERK signaling pathway. We found
that CSW loss-of-function mutations extended life span by interacting with components
of the insulin signaling pathway and impairing AKT activity in adult flies. By expressing
csw-RNAi in different organs, we determined that CSW extended life span by acting in
organs that regulate energy availability, including gut, fat body and neurons. In contrast
to that in control animals, loss of CSW leads to reduced homeostasis in metabolic rate
during activity. Clinically relevant gain-of-function csw allele reduced life span, when
expressed in fat body, but not in other tissues. However, overexpression of a wild-
type allele did not affect life span, showing a specific effect of the gain-of-function allele
independently of a gene dosage effect. We concluded that CSW normally regulates life
span and that mutations in SHP2 are expected to have critical effects throughout life by
insulin-dependent mechanisms in addition to the well-known RAS-ERK1/2-dependent
developmental alterations.
Keywords: CSW loss and gain-of-function mutations, life span, Drosophila, insulin signaling, metabolism
INTRODUCTION
Normal tissue functions, including growth, maintenance, and regeneration, depend on the
availability of energy provided by food or reservoirs like glycogen and lipids. In mammals,
growth depends on growth hormone and, in turn, insulin-like growth factors (e.g., IGF1), which
promote the activation of the RAS-ERK1/2 signaling pathway. On the other hand, insulin signaling
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promoting the activation of PI3K-AKT signaling pathway plays
an essential role in growth and energy balance. In Drosophila,
both functions are mediated by the insulin and insulin-like
growth factor signaling (IIS) pathway downstream of a single
insulin receptor (InR) (Reyes-DelaTorre et al., 2012; Rajan and
Perrimon, 2013). Like humans, Drosophila regulates its levels of
circulating carbohydrates and stores excesses as glycogen and
lipids, mainly triglycerides (TGs), in the fat body (Teleman,
2010). A large number of studies have shown evolutionarily
conserved functional signaling mechanisms between fruit flies
and vertebrates, like the insulin/IGF/target of rapamycin pathway
(Oldham and Hafen, 2003; Reyes-DelaTorre et al., 2012).
Accumulating evidence shows that insulin signaling affects
metabolism in vertebrates and invertebrates with profound
effects on survival (Kenyon et al., 1993; Böhni et al., 1999; Clancy
et al., 2001; Tatar et al., 2001; Blüher et al., 2003).
The protein tyrosine phosphatase (PTP) SHP2, encoded
by PTPN11 (OMIM# 176876), is a ubiquitously expressed
protein acting downstream of many receptor tyrosine kinases,
including InRs (Kuhné et al., 1993; Perkins et al., 1996).
SHP2 is involved in development and developmental disorders
such as Noonan syndrome (NS; OMIM# 163950) and NS
with multiple lentigines (NSML; OMIM# 151100; formerly,
LEOPARD syndrome) (Tartaglia et al., 2001; Digilio et al., 2002).
These disorders are part of a larger group of disorders named
the RASopathies, caused largely by gain-of-function (GOF)
mutations that enhance the activity of the RAS-ERK1/2 signaling
pathway (Tartaglia and Gelb, 2005; San Martín and Pagani,
2014; Jindal et al., 2015). SHP2 is a proto-oncogene, and growth
alterations as well as higher incidence of malignancies have
been documented in the RASopathies (Tartaglia et al., 2003;
Tartaglia and Gelb, 2005; Chan and Feng, 2007). Moreover, SHP2
is involved in proliferation and differentiation of stem cells in
different tissues and developmental stages (Qu and Feng, 1998;
Ke et al., 2007; Wu et al., 2009; He et al., 2013). Of note, normal
stem cell –functions are required for tissue homeostasis and
regeneration throughout life, for which insulin signaling seems
to be critical in a nutrition-dependent manner (Biteau et al., 2010;
Shim et al., 2013).
Whereas mutant mice lacking Shp2 die during development,
mice heterozygous for the knock-out allele showed no effect on
insulin sensibility or insulin signaling activity (Arrandale et al.,
1996; Saxton et al., 1997). The main effect of a reduction of
SHP2’s phosphatase activity in all cells of an animal remained
elusive until recently. Reduced SHP2 function by a loss-of-
function (LOF) mutation T468M modeling NSML showed
increased tolerance to both insulin and high-fat diets (Tajan
et al., 2014). However, this and other NSML-associated mutations
(i.e., T468M and Y279C) showed reduced phosphatase activity,
but GOF effects in development as well as enhanced ERK1/2
signaling activity during development or after insulin injection
(Oishi et al., 2009; Tajan et al., 2014) presumably through
phosphatase-independent SHP2 functions (Stewart et al., 2010).
Of note, NSML and NS are also caused by GOF mutations in
RAF1 (Pandit et al., 2007).
Taken together, this evidence suggested that mutations in
SHP2 might produce an altered regulation of mechanisms
involved in metabolism and tissue homeostasis. However, the
effect of a global SHP2 reduction on metabolism and life span,
as well as the pathological implications, remains elusive. Here, we
examined the effect of genetic manipulations of SHP2 on life span
and metabolism using a Drosophila model system.
MATERIALS AND METHODS
Drosophila Stock and Culture
Flies were raised on standard yeast and sucrose-based food,
at 25◦C or 29◦C and 65% humidity, on a 12-h light/dark
cycle, unless otherwise indicated. The control line w1118 was
generated by crossing separate inbred w1118 lines (FBst0003605)
and established before use. This ensured a healthy life span
by avoiding inbreeding depression in the control group.
The following stocks were obtained from the Bloomington
Drosophila Stock Center: w1118, cswlf/FM7 (FBst0023873),
csw6/FM7 (FBst0023876), FB-r4Gal4 (FBst0033832), Arm-Gal4
(FBst0001560), elavC155-Gal4 (FBst0000458), DJ757-Gal4
(FBst0008184), Ilp2-Gal4 (FBst0037516), esg-Gal45730
(FBst0026816), chico1/cyo (FBst0010738), InRE19/TM2
(FBst0009646), and BxMS1096-Gal4 (FBst0008860) and from the
Vienna Drosophila RNAi Center UAS-csw-RNAi (FBst0454218).
The following lines were kindly provided by B. Gelb (UAS-cswWT
and UAS-cswT73I) and Y. Zhong (Cy/Sp;Sb/Ser). Mutants and
transgenic flies were backcrossed to the control line w1118 for
five generations to eliminate differences in genetic background.
These lines are described in flybase.org.
Life Span Analysis in Poor and Rich Diets
and Starvation
Female flies were collected within 48 h of eclosion under brief
CO2 anesthesia (less than 2 min) and kept at a density of 25–
30 female flies per vial in controlled 12-h light/dark cycle. For
life span experiments, flies were kept at 29◦C in 65% humidity,
and in some cases, the same experiment was also performed at
25◦C. At least three independent experiments were performed
for each condition and genotype. Vials were changed three times
a week, and the number of dead flies was counted. For life span
in poor and rich diets, flies were treated in the same way as life
span analysis (29◦C in 65% humidity) but collected and kept in
vials containing 0.25% or 15% yeast media for poor and rich
diets, respectively. For starvation-resistance experiments, flies
were raised and collected in the same way as life span experiments
and kept at 29◦C in controlled 12-h light/dark cycle in vials
containing agar 1%. Vials were changed every 3 h seven times a
day. Prism (GraphPad) software was used to build survival curves
as Kaplan–Meier survival plot and comparisons by log-rank and
Gehan–Wilcoxon tests corrected for multiple comparisons.
Western Blot Analysis
Four adult flies of the corresponding feeding condition were
lysed in 50 µl of EBR buffer [2 mM of Cl2Ca, 129 mM
of NaCl, 4 mM of KCl, and 35 mM of Tris (pH 6.85)]
supplemented with phosphatase/protease inhibitor cocktail
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(Sigma #P2714), NaF (50 mM), and sodium orthovanadate
(1 mM). A 12 mg protein/lane and a 24 mg protein/lane were used
for pERK and pAKT immunoblots, respectively. Tissue samples
were run on 12% sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS–PAGE) and transferred to polyvinylidene
difluoride (PVDF) (Thermo Scientific). Primary antibodies used
were as follows: anti-pAKTSer 505 1:1,000 (Cell Signaling #4054),
anti-AKT 1:1,000 (Cell Signaling #9272), anti-pERK1/2 1:1,000
(Sigma #M8159), and anti-ERK1/2 1:15,000 (Sigma #M5670).
Horseradish peroxidase (HRP)-conjugated secondary antibody
goat anti-mouse 1:1,000 (Sigma #A5278), goat anti-rabbit 1:5,000
(Sigma #A0545), and Super Signal West Pico (Thermo Scientific)
were used for signal detection in an ImageQuant RT ECL (GE
Healthcare Life Sciences) device. Activation was quantified by
ImageJ 1.47v as phospho-protein normalized to non-phospho-
protein (pERK/ERK and pAKT/AKT).
Immunohistochemistry
For staining against phospho-AKTSer 505, female flies were fasted
for 16 h in agar 1% and after that fed in standard fly media for
4 h when animals were anesthetized in iced water. Guts were
dissected on ice, immediately fixed in paraformaldehyde (PFA)
4% for 20 min at room temperature, washed with phosphate-
buffered saline (PBS) 0.1 M, and incubated with methanol during
5 min at −20◦C. Then, guts were rinsed on PBS 0.1 M and
incubated with Tris-HCl 150 mM, pH 9.0, at 70◦C during 15 min
for antigenic exposure. After being rinsed with PBS 0.1 M and
incubated with PBS-T during 15 min, guts were blocked with
PBS-T and bovine serum albumin (BSA) 2% for 30 min at room
temperature and incubated with the primary antibody overnight
at 4◦C. After that, guts were rinsed on PBS-T and incubated
with the corresponding secondary antibody for 2 h at room
temperature. For staining against phospho-ERK, female flies were
fed for 16 h with H2O2 1% in sucrose 5% and, after that, fed
with standard fly media for 24 h when animals were anesthetized
in iced water processed for immunostaining as before without
antigenic exposure. The following primary antibodies were used:
rabbit anti-pAKTSer 505 1:1,000 (Cell Signaling #4054) and mouse
anti-pERK1/2 1:1,000 (Sigma #M8159). Secondary antibodies
were goat anti-rabbit Alexa Fluor 555 (#A-21429) and goat anti-
mouse Alexa Fluor 488 (#A-11029) from Life Technologies.
DAPI and propidium iodide were used to stain DNA. Images
were collected with BX53 epifluorescence microscope and a
Q-color 5 digital camera (Olympus Optical) and processed
using Image J 1.47v.
Triglyceride Determinations
Females flies aged 3–5 days of each genotype were placed in
groups of 25–30 in vials containing standard fly media. For
TG determinations in hemolymph, flies were cold anesthetized,
and hemolymph was extracted by puncturing the thorax with
0.27-mm entomological needle follow by centrifugation at
2,600 g for 5 min at 4◦C. For TG determinations in abdominal
segments, five flies were cold anesthetized, and their abdomen
was separated and homogenized in 40 µl of lysis buffer (0.2%
Tween 20 and PBS 0.1 M). The TG levels were determined by
spectrometry according to manufacturer’s instructions (TG Color
GPO/PAP AA Wiener Lab). Each experiment was repeated at
least three times.
Respirometry
A Sable Systems International (SSI) system was used for
flow-through respirometry supplemented by an optical activity
detector SSI AD-2. Temperature was controlled to 25 ± 0.1◦C
by a SSI Pelt-5 temperature controller coupled to a SSI Peltier
Plate. Room air was pushed through a Drierita–Ascarita–Drierita
column to scrub off water vapor and CO2 at a standard
temperature and pressure (STP)-corrected flow rate of 50 ml
min−1 by a Side-Trak Model 830 mass-flow valve (Sierra
Instrument, CA, United States) connected to a MFC-2 mass-
flow controller (SSI). The prepared air is then entered into
SSI thermal respirometry chamber (internal volume < 1 ml).
Finally, air left the respirometry chamber (having gathered CO2
from the insects on its way) and entered the Li-Cor (LI-6251)
CO2 infrared analyzer (Lincoln, NE, United States; resolution
0.1 ppm of CO2). The analog outputs from the analyzers
measuring CO2, fly’s activity, temperature of the chamber, and
air flow rate were connected to a A/D converter (SSI UI-2,
16-bit basic accuracy = 0.05%) and stored in a computer by
ExpeData data acquisition software (SSI) for further analyses
(Schilman et al., 2011).
An individual female Drosophila was transferred from the
breeding container to a 2-ml vial and then placed into the
chamber. The fly was minimally handled, no thermal or chemical
tranquilization was applied, and the experimental temperature
was the same to that of the rearing one. The recording began
with a baseline segment to establish the zero points for the carbon
dioxide and activity analyzers. After that, the CO2 released by the
fly was measured for 20 to 50 min, plus another baseline. Data
points were taken at 1-s intervals (1 Hz).
For each recording, CO2 baselines were subtracted assuming
a linear drift and converted from parts per million to microliter
per hour and to energy units of microwatt using a respiratory
quotient (RQ) = 1. Mass-independent metabolic rate was
calculated by dividing catabolic flux rates in microwatt by live
mass in milligrams raised to the 0.856th power, which is the inter-
specific mass scaling exponent for tracheate arthropods (Lighton
et al., 2001). Fresh body weight was determined by weighting
female flies, under ad libitum conditions, in groups of 20–25 flies
in a Sartorius 2474 scale.
In order to compare activity from different flies and
recordings, an index of activity was calculated. To do this, activity
was converted to the absolute difference sum (ADS), that is,
the cumulative sum of the absolute difference between all of
adjacent data points, data stored into a new different channel, and
the index of activity calculated based on the equation: Activity
index = ADS range/N∗60, where ADS range is the difference
between maximum and minimum values of ADS activity and N
is the number of samples or seconds of the recording.
Climbing Assay
Climbing assays were performed as previously described
(Gargano et al., 2005). In brief, 20–30 flies were placed in empty
vials and, after 1 min of rest, gently tapped three times to move
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flies to the bottom. After 4 s, the position of the flies in each
tube was registered with a digital camera connected to a PC.
The camera was controlled by a MATLAB script that detected
the vials’ movement considering as time 0 when the vials stop
moving. After 1 min of rest, this procedure was repeated four
more times, and the average position of the flies in the vial was
calculated, with other MATLAB script, to generate a single data
(N = 1).
Statistical Analysis
Statistical analysis was performed using Prism GraphPad 6.01
software. Comparisons of survival curves as Kaplan–Meier
survival plot were performed by log-rank and Gehan–Wilcoxon
tests corrected for multiple comparisons. Shapiro–Wilk’s test was
used to evaluate data normality. For the purpose of checking
statistical significance between two groups, unpaired t-test or
Mann–Whitney test were used for parametric or non-parametric
analysis, respectively. One-way ANOVA or Kuskal–Wallis was
used for comparison of statistical significance between more
than two groups for parametric or non-parametric analysis,
respectively. Two-way ANOVA was used for comparison between
groups with two factors followed by Sidak’s multiple comparison
test. Statistical significance was defined as p < 0.05.
RESULTS
Previous studies in mammalian models found that knock-in LOF
or knock-out of SHP2 in specific tissues increased tolerance to
insulin (Matsuo et al., 2010; Nagata et al., 2012; Tajan et al.,
2014). Because we wanted to determine whether we could use
fruit flies to investigate the role of SHP2 in metabolism and life
span, we began by examining the effect of reducing CSW in fruit
flies on life span.
Loss-of-Function csw Increased Median
Life Span and Longevity
To understand the role of SHP2 in survival, we investigated the
effect of suppressing CSW function, the orthologous phosphatase
in Drosophila. First, we ensured that the genotype to be used as
control, w1118, showed a healthy life span similar to that of a wild-
type (WT) group (see Methods). Then, we analyzed the effect of
the weakest hypomorphic allele csw6 on survival (Perkins et al.,
1996), because csw-RNAi expressed in the whole body was lethal.
For this experiment, we used female fruit flies heterozygous
for csw6, because it is lethal in males (Perkins et al., 1996).
The reduced function of CSW in this hypomorphic genotype
showed an increase in median life span and maximum life span
compared with those in the control group at 29◦C (Figure 1A)
or at 25◦C (Supplementary Figure S1A). This increase in
survival showed a similar proportion at both temperatures
(Supplementary Figures S1B,C). To confirm that reducing CSW
function increased survival, we examined the effect of a second
weak hypomorphic allele cswlf, also using female flies due to male
lethality. This second csw allele produced a comparable increase
in both features of survival (Figure 1B).
We confirmed the LOF effect of cswlf, which consists
of a typical LOF wing vein phenotype (Oishi et al., 2006)
(Supplementary Figures S1D,E). Taken together, these
observations suggested that LOF csw allele in the whole
organism increased survival. Next, we focused on potential
mechanisms mediating these effects.
Loss-of-Function csw Extended Life
Span by Interacting With
Insulin/Insulin-Like Growth Factor
Signaling and Reducing AKT Activation
Reduction in the IIS pathway has been shown to increase life
span in organisms ranging from yeast to mammals. Consistent
with this, SHP2 has been reported to be a positive regulator of
both insulin-dependent activation of ERK1/2 through RAS and
IGF1-dependent activation of PI3K in mammalian cell cultures
(Figure 2A) (Yamauchi et al., 1995; Wu et al., 2001). In addition,
SHP2 also participates as a negative regulator of the insulin-
dependent activation of PI3K through the InR substrate (IRS),
the mammalian ortholog of chico (Myers et al., 1998) (Figure 2A).
Therefore, we hypothesized that the life span extension observed
in csw6 flies might be due to a decline in CSW as a positive
regulator on the IIS pathway.
To begin examining this possibility, we performed gene
interaction studies using LOF alleles of genes with well-
established effect on life span, InR and chico. If the effect of csw6
on survival is mediated by a mechanism independent of the IIS
pathway, an additive effect would be expected in an InR and csw
double mutant. However, if csw6 extended life span through the
IIS pathway, an interaction should be observed, as previously
reported for InR and chico (Böhni et al., 1999). To test this, we
analyzed the effect of a weak LOF allele, InRE19, which has been
shown to reduce insulin-like receptor activity in heterozygous
fruit flies (Tatar et al., 2001). For these experiments, we used
female fruit flies to make it comparable with LOF csw females.
As expected, the InRE19 allele increased survival compared with
the control group +/+ and was similar to csw6/+. The double
mutant (csw6/+; InRE19/+) did not show an additive effect in life
span (Figure 2B).
To further support our observation that csw6 extended life
span by interacting with molecular components of the IIS
signaling, we examined the interaction of csw6 with chico1, which
has been shown to extend life span (Clancy et al., 2001). Similar
to what we observed for InRE19, chico1/+ increased survival,
whereas the double mutant (csw6/+; chico1/+) did not show an
additive effect (Figure 2C). Together, these results suggested that
LOF csw might be extending life span through IIS reduction.
The genetic interaction data suggested that LOF csw reduces
the insulin signaling pathway, resulting in life span extension.
To confirm this interpretation, we examined the activity levels
of AKT and ERK as a read-out of the activity levels of the IIS
pathway by western blot in the whole body of LOF csw flies
fed ad libitum, starved, and at different times after refeeding.
The response of AKT and ERK activation to the feeding
conditions in the LOF csw was undistinguishable from that
of the control group (Supplementary Figures S2A–D). We
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reasoned that possible differences in specific tissues might be
diluted in the mix of tissues of the whole body. To examined
this possibility, we used immunostaining to assess AKT and
ERK activation in the gut, an important organ in determining
survival in an IIS-dependent manner (Biteau et al., 2011;
Rera et al., 2012).
We examined adult LOF csw and control flies after 16 h
of fasting followed by 4 h of refeeding. We found reduced
pAKT staining in the CSW mutant compared with control
in areas corresponding to the plasma membrane, cytoplasm,
and nucleus (Figures 2D–F). In addition, in the control
group, there was a higher activation of AKT in the plasma
membrane or in the nucleus compared with the cytoplasm
(p < 0.05), whereas there was no such difference in the CSW
mutant. Moreover, no staining for the activated form of ERK
was detected. We confirmed that ERK was activated in the
gut in our flies after tissue damage as has been previously
reported (Jiang et al., 2011) (Supplementary Figure S3),
validating that assay.
These results showed that LOF csw interacts with IIS
pathway components and impairs AKT activation and
localization in specific tissues with no effect on ERK
activity in adult animals. Therefore, we concluded that
CSW normally participates in the IIS pathway in adult
fruit flies as suggested by studies in vertebrate cell cultured
(White, 2002; Matsuo et al., 2010; Nagata et al., 2012; Tajan
et al., 2014) with a positive effect in gut in our conditions
(Figures 2D–F). Of note, LOF csw showed no effect on
ERK activity in adult fruit flies in various feeding conditions
(Supplementary Figure S2).
Loss-of-Function csw Increased Life
Span in Poor and Rich Yeast Diets
Our previous observations suggested that LOF csw alleles
promote life span by reducing insulin signaling. To further
understand the relation of CSW with the IIS pathway, we
examined whether LOF csw affected life span in poor and rich
yeast diets as previously reported for mutants of the IIS pathway
(Min et al., 2008). In parallel experiments, we analyzed the
life span of the IIS mutants InRE19/+ and chico1/+ to these
diets. As expected, LOF csw, InR, and chico mutants showed
extended life span with a normal yeast diet as compared with
the control group (Figure 2G). Survival curves for poor diet
containing 0.25% of yeast appear to show that all genotypes had a
reduced survival compared with themselves on regular fly media
(compare Figures 2G,H). Although insulin mutants InRE19/+
and chico1/+ showed a higher survival than did the control
group, it was smaller compared with that of the LOF csw6/+
(Figure 2H). Similarly, with a rich diet containing 15% yeast,
the insulin mutants InRE19/+ and chico1/+ and the LOF csw6/+
showed a longer life span in rich diet than did the control group
(Figure 2I). Of note, median life span of LOF csw was insensitive
to rich diet (Supplementary Figure S4).
Taken together, these experiments showed that LOF csw as well
as LOF insulin mutants provided extended life span in poor and
rich diets, further supporting a role of CSW in the IIS pathway.
Suppression of csw in Fat Body or
Neurons Is Required for Life Span
Extension
The effect of LOF csw by using the hypomorphic allele
csw6 or cswlf was effective in extending life span. The IIS
pathway is a key regulator of energy resources in the fat
body, neurons, and muscle tissue (Colombani et al., 2003;
Géminard et al., 2009; Rajan and Perrimon, 2012; Wang
et al., 2014). Thus, we wanted to determine whether LOF csw
extended life span by acting in those tissues. First, using the
GAL4/UAS system (Brand and Perrimon, 1993), we examined
the effect of the RNA interference (RNAi) UAS-csw-RNAi,
which has no predicted off-target sequences and specifically
reduced CSW protein levels (Dietzl et al., 2007; Pagani et al.,
2009). This csw-RNAi produced lethality when it was expressed
in the whole body—by Actin-GAL4 or Tubulin-GAL4—and a
smaller wing phenotype when expressed in the wing by Bx-
GAL4, similar to the suppression of RasD85 (Supplementary
Figure S5) (Terriente-Félix and de Celis, 2009; Hahn et al.,
2013). We drove the expression of csw-RNAi to neurons,
muscle, and fat body by using previously characterized tissue-
specific GAL4 drivers (elavC155-GAL4, DJ757-GAL4, and FBr4-
GAL4, respectively) (Lin and Goodman, 1994; Seroude et al.,
2002; Lee and Park, 2004; Vrailas-Mortimer et al., 2011).
Note that DJ757-GAL4 also showed some expression in the
brain and fat body (Seroude et al., 2002). We confirmed
the appropriate expression pattern of those GAL4 drivers by
expressing red fluorescent protein (UAS-RFP) and detected their
expression pattern.
Reducing CSW activity in muscle had no effect on survival
(Figure 3A). However, expressing csw-RNAi in neurons or in
the fat body increased life span compared with that in parental
controls (Figures 3B,C). These observations are consistent with
the current model in which the fat body and neurons control the
activity levels of the IIS pathway of all peripheral tissues (Rajan
and Perrimon, 2013; Wang et al., 2014). In this model, the fat
body senses the feeding state and signals to insulin-producing
cells (IPCs) in the brain, which, in turn, promote insulin-like
peptide 2 (Dilp2) release. Dilp2 released from IPCs binds to
InR in different tissues and activates the IIS pathway (Wang
et al., 2014). Because suppression of CSW in neurons extended
life span, we wanted to determine whether those neurons were
IPCs. Thus, we examined whether csw-RNAi expressed in an IPC
pattern (ILP2-GAL4) modulates life span. Although the statistical
analysis indicated a significant difference (p < 0.01) (Figure 3D),
this manipulation did not affect maximum or median life span.
Therefore, other neurons in addition to IPCs must be involved in
the csw-dependent life span extension (compare Figures 3B,D).
Moreover, the gut appears to be an important determinant
of survival in an IIS-dependent manner through systemic and
local effects (Biteau et al., 2011; Rera et al., 2012). Thus, we
examined life span after suppressing csw in intestinal stem cells
(ISCs) and enteroblasts by using the specific drivers esg-GAL4
and csw-RNAi (Micchelli and Perrimon, 2006). Expression of
csw-RNAi increased survival compared with that of the parental
lines (Figure 3E).
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FIGURE 1 | Loss-of-function (LOF) csw mutations extend life span. Effect of reducing the tyrosine phosphatase CSW on life span at 29◦C. (A,B) Life span was
extended by the classical csw LOF mutations csw6/+ (A) and cswlf/+ (B) compared with a control group (+/+). All the three genotypes share the same genetic
background of w1118. Log-rank test. The number of animals was n = 103 to 149, at least from four independent experiments.
Of note, whereas suppressing CSW function in neurons or the
fat body increased median life span but not maximum life span
(Figures 3B,C), the esg-GAL4;csw-RNAi increased maximum
life span but not median life span. This result of survival
(Figure 3), together with the effect of LOF csw on AKT activity
(Figures 2D–F), might suggest that CSW increased maximum
life span through the IIS pathway by local effects, whereas it
increased median life span by systemic ones. Furthermore, these
data are consistent with a model in which CSW has differential
impact on distinct body organs, and those may contribute
additively to survival.
These observations showed that by reducing the activity of
CSW, life span was extended through action in specific tissues.
Consistent with a function of CSW in IIS as a positive regulator,
LOF csw appeared to extend survival through organs involved
in the regulation of energy resources acquired by feeding, like
the gut, fat body, neurons, and IPCs (Colombani et al., 2003;
Géminard et al., 2009; Rajan and Perrimon, 2012).
Loss-of-Function csw Enhanced
Resistance to Starvation With Higher
Triglyceride Levels
The studies presented above indicated that CSW controls
metabolism and life span through the IIS pathway. Previous
reports showed that LOF insulin mutants contain increased lipid
content and normal protein levels (Böhni et al., 1999). Fat tissue
reservoirs play a key role as energy resource in food shortages,
in a way that animals with higher initial adiposity survive longer
in starvation (Cherel et al., 1992; Caloin, 2004). Therefore,
we wanted to determine whether LOF csw mutants showed
resistance to starvation and altered lipid and protein content.
First, we examined starvation resistance in adult LOF csw
fruit flies maintained in a fly media composed of agar 1%,
which provide mainly a source of water. We found that LOF
csw flies had high resistance to starvation as compared with the
control group (Figure 4A). Next, we examined circulating TG
content in hemolymph, as well as total content of TG in the
abdominal segment, where most of the fat body is located. LOF
csw showed normal levels of TG in hemolymph but increased
levels in the abdominal segment as compared with control
group (Figures 4B,C), whereas protein levels were unaffected
(Figure 4D). The higher resistance to starvation can be explained
by the higher TG content when starvation began (Caloin, 2004).
Taken together, these results are consistent with a role of CSW
in IIS signaling mechanisms (Figure 2). Moreover, the extended
life span of LOF csw in starvation and rich yeast diet (Figures 2,
4) strongly suggests a role of CSW in metabolic regulation.
Loss-of-Function csw Impairs Metabolic
Rate Homeostasis
To gain insight into how the PTP CSW is related to metabolism,
we measured the metabolic rate at rest and during activity in
single fruit fly experiments using a high-resolution setup at
constant temperature (25◦C). Young (3–5 days) and old (37–
39 days) LOF csw or control females were transferred to the
respirometry chamber, and the CO2 production together with the
levels of activity and temperature was recorded in real time.
Mass-specific metabolic rate and mass-specific standard or
resting metabolic rate of LOF csw animals were indistinguishable
from those of the control group in young (Figures 5A,B) and old
fruit flies (Supplementary Figure S6). Consistent with studies on
IIS pathway mutants (Hulbert et al., 2004), LOF csw produced no
effect on average metabolic rate.
Interestingly, in a regression analysis of the average metabolic
rate over activity index, there was no significant slope in the
control group (i.e., young and old flies), showing that the
metabolic rate appears to be constant at different levels of
activity (Figures 5C,D). In contrast, LOF csw appears to lack
this homeostatic mechanism because the metabolic rate increased
together with their activity levels, showing a significant slope
in young (p = 0.0008, R2 = 0.31) and old animals (p = 0.0001,
R2 = 0.33) (Figures 5C,D). In other words, CSW seems to
contribute in the maintenance of a constant metabolic rate
with larger activity because such functional property was lost in
csw mutants.
Although there was a main effect of genotype over activity,
the LOF csw fruit flies in each age group showed normal
average activity levels as compared with the control group
in respirometry assays (Figure 5E) and in climbing assays
throughout life (Figure 5F).
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FIGURE 2 | Loss-of-function (LOF) csw interacts with the insulin pathway reducing AKT activation and extended life span in poor and rich diets. (A) Simplified
schematic representation of the roles of the vertebrate tyrosine phosphatase SHP2 and ortholog of CSW in fruit flies. Arrows indicate positive regulatory effects, and
blunt arrow indicates negative regulatory effect. Note the predominant positive effect of SHP2. (B,C) Non-additive effect on life span curves by genetic interaction of
LOF csw6 with classical insulin mutants, InRE19 and chico1. (B) Double mutant csw6; InRE19 compared with single mutants (csw6;+ and +;InRE19) and +;+ (control).
(C) Double mutant csw6; chico1 compared with single mutants (csw6;+ and +;chico1) and +;+ (control). (D–F) Immunostaining showing reduced AKT activation in
LOF csw posterior midguts, using anti-pAKT. Representative staining in control (D) and LOF csw6 gut (E) showing pAKT, DNA staining (D’,E’), and merged staining
(D”,E”). Scale bar 10 µm. (F) Average optical density of pAKT, corresponding to plasma membrane, cytoplasm, and nucleus for mutant (csw6/+) and control (+/+)
fruit flies. Each bar represents 40 data points from four different animals. Asterisks indicate significant reduction in csw6/+ compared with control guts,
∗∗p < 0.0001; ∗p < 0.05; and # indicates significant reduction in cytoplasm compared with plasma membrane or nucleus in control group, two-way ANOVA, Sidak’s
multiple comparison test. (G–I) Survival curves showing extended life span in poor and rich yeast diets of csw6/+ and classical insulin mutants, InRE19/+ and
chico1/+, compared with control group +/+ cultured in fly media containing the concentrations of yeast: 2% (G), 0.25% (H), and 15% (I). The three mutants showed
extended life span as compared with control group, p < 0.0001, log-rank test, corrected for multiple comparisons. For the panels (B,C,G–I), the number of animals
was n = 61 to 129, at least from three independent experiments.
This result seems to provide evidence of the existence of a
homeostatic mechanism for metabolic rate, in which CSW and
perhaps the IIS pathway might be involved.
Overexpression of Gain-of-Function csw
in the Fat Body Reduced Life Span
Our experiments indicated that CSW may have a role in normal
physiology affecting the IIS pathway, metabolic rate, and life
span. Therefore, it is possible that similar alterations would be
implicated in cases of NS with mutated SHP2. However, this
and related disorders are largely produced by GOF mutations
in components of the RAS-ERK1/2 signaling pathway, which
produce an enhancement of this pathway. Thus, to test the
potential clinical relevance of the csw-dependent effects on life
span, we analyzed the effect of enhancing CSW functions by
overexpressing a WT allele and a GOF one, which show the
same expression level of CSW protein (Pagani et al., 2009),
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FIGURE 3 | Loss-of-function (LOF) csw extends life span acting in specific tissues. (A–E) Survival curves showing the effect of the csw-RNAi driven to the following
tissues: (A) Muscle by the specific GAL4 driver (DJ757/csw-RNAi) and parental lines (+/csw-RNAi and DJ757/+). (B) Neurons by the specific GAL4 driver
(elav;csw-RNAi) and parental lines (+;csw-RNAi and elav;+). (C) Fat body by a specific GAL4 driver (FB;csw-RNAi) and parental lines (+;csw-RNAi and FB;+).
(D) Insulin-producing cells by a specific GAL4 driver (ILP2;csw-RNAi) and parental lines (+;csw-RNAi and ILP2;+). (E) Intestinal stem cells and enteroblasts by a
specific GAL4 driver (esg;csw-RNAi) and parental lines (+;csw-RNAi and esg;+). Note that csw-RNAi increased survival when expressed in neurons, fat body, and
gut compared with parental lines. (F) Median and maximum life span was higher in flies expressing csw-RNAi in fat body or neurons than in IPCs. Statistical
significance by log-rank test, corrected for multiple comparisons. The number of animals was n = 80 to 149, at least from four independent experiments. ∗p < 0.05.
allowing us to exclude differences from these transgenes owing
to expression levels.
Ubiquitous overexpression of csw WT with the Armadillo-
GAL4 driver (Arm-GAL4;cswWT) or in specific tissues such as
neurons, muscle, or fat body using the same GAL4 drivers
used for csw-RNAi expression (i.e., elav-GAL4, DJ757-GAL4,
and FBr4-GAL4) did not alter life span (Figures 6A,B and
Supplementary Figure S7). This indicated that an increase in
CSW function of a WT protein has no specific or non-specific
deleterious effects.
Next, we examined the effect on life span of the GOF csw
allele T73I, which models the most frequent human mutation
involved in leukemia in NS (Oishi et al., 2006; Chan and Feng,
2007) and express fivefold more CSW protein than did the
non-transgenic control flies (Pagani et al., 2009). As expected,
the expression of the GOF csw allele T73I (UAS-csw-T73I)
to the wing by using Bx-GAL4 produced an ectopic wing
vein (Supplementary Figure S8), confirming its GOF effect in
development as previously reported (Oishi et al., 2006). The
expression of the GOF csw allele T73I (UAS-csw-T73I) in the
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FIGURE 4 | Loss-of-function (LOF) csw provides resistance to starvation with increased triglycerides levels. (A) Survival curves showing higher resistance to
starvation in LOF csw mutant compared with control group, log-rank test (n = 101 and 102, respectively, from five independent experiments). (B,C) Triglyceride
levels of LOF csw mutant compared with control group, in hemolymph (mg/ml) (B) (n = at least four independent experiments); bars, mean ± SEM (p > 0.05 t-test)
and in abdominal segment (C) (n = 10) (∗p < 0.05 Mann–Whitney test); bars, median ± interquartile range (IQR). (D) Protein levels of LOF csw mutant compared
with control group, n = 10, p > 0.05 t-test.
whole body by Tub-GAL4 was lethal, whereas the armadillo-
GAL4 driver (Arm-GAL4/cswT73I) produced viable progeny.
However, the overexpression of the T73I allele in the whole body
or in specific tissues such as neurons or muscle did not cause any
effect on life span (Figures 6C–E). In contrast, overexpressing the
GOF csw allele T73I in the fat body reduced life span as compared
with control groups at 25◦C (Figure 6F) but not at 29◦C
(Figure 6G), although both curves showed a similar tendency
in early life. Consistent with that finding, the overexpression of
the csw WT allele in the fat body produced a similar, but not
significant, decrease in survival in the first portion of the life
span curve when flies were cultured at 25◦C but had no effect
when cultured at 29◦C (Figures 6A,B). Most importantly, these
data also indicate a specific effect of the GOF csw mutation, but
not an effect of overexpression, because overexpressing WT csw
transgene did not affect life span (Figures 6A,B).
Altogether, these results further support a role of CSW in the
regulation of fat body functions related with the IIS pathway.
Surprisingly, it was easier to extend life span than reduce it by
manipulating csw, because only the manipulations in fat body
could reduce life span (Figures 1, 3, and 6). However, this
fact strengthens the idea of a specific role of csw in the fat
body, instead of a non-specific effect of transgenic suppression
of csw. Therefore, these data predict that GOF SHP2 may have
a pathological effect in humans and expand the current model
of molecular pathogenesis in NS of enhanced RAS-ERK1/2
signaling (see Discussion).
DISCUSSION
These studies advanced our understanding on the role
and mechanisms of the phosphatase CSW/SHP2 in adult
organisms, which appears to be unrelated with the regulation
of ERK1/2 signaling activity, previously described in a context
of development, as well as long-term memory deficits in
adult animals (Jindal et al., 2015). The study also provides
insight into insulin-mediated processes and their underlying
mechanisms, which is of great interest for human health owing
to its essential roles in diabetes, metabolism, aging, and cancer
(Reyes-DelaTorre et al., 2012; Rajan and Perrimon, 2013).
Overall, this study showed that CSW plays an important role in
life span in a signaling pathway involving InR and chico.
Taken as a whole, these findings expand the current model
of the molecular pathogenesis in NS (i.e., enhanced RAS-
ERK1/2 signaling) and predict a more comprehensive model that
includes altered RAS-ERK1/2 and insulin signaling mechanisms
as well, affecting metabolism throughout life. Importantly, we
showed that CSW has distinct effects on molecular signaling
in development and in adult animals. This fact has important
implications on the molecular pathogenesis of NS and related
disorders. For instance, the rational drug design for NS and
related disorders has been directed to reducing the enhanced
RAS-ERK1/2 signaling (Li et al., 2005; Wang et al., 2012),
which might be not appropriate for adult subjects or metabolic
alterations. The clinically relevant GOF CSW mutant protein
acting in the fat body reduced survival (Figure 6), predicting
altered metabolism throughout life in subjects carrying GOF
SHP2 mutant proteins. This prediction is consistent with the
resistance to diet-induced obesity observed in a mouse model of
NSML and its correlation in patients (Tajan et al., 2014).
CSW and Life Span
We showed that the phosphatase CSW participates in the
regulation of life span, similar to other classical insulin pathway
mutants in several features. The csw-dependent life span effect
was positively and negatively modulated by LOF and GOF
alleles in the fat body, respectively. However, a functional
role of CSW in other important tissues for nutrient-dependent
metabolism (IPCs, neurons, and gut) was revealed by a csw-RNAi.
Because overexpressing csw WT allele did not affect survival
(Figures 6A,B and Supplementary Figure S7), we can exclude
a gene–dose effect of the GOF allele. This supports the notion
that the effect of the GOF allele is specific to the mutant allele,
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FIGURE 5 | Loss-of-function (LOF) csw impairs metabolic rate homeostasis. (A,B) Mass-corrected metabolic rate (µW mg-0 .856) (A) and mass-corrected standard
metabolic rate (µW mg-0 .856) (B) in LOF csw mutants (n = 10) compared with control group (n = 9). Bars, means ± SEM. (C,D) Linear regression of metabolic rate
(MR) over activity index in young (3–5 days) (C) and old fruit flies (37–39 days) (D) in LOF csw and control group (n = 28–35). Each point represents a 5-min trace
recording. Note that LOF csw flies show a significant linear relation of MR over activity index (p = 0.0008) and (p = 0.0001) for young and old flies, respectively. (E,F)
Activity levels measured in experiments of respirometry within age group (E) (n = 28–35), and climbing assays throughout life (F) were not affected by LOF csw
compared with control group, two-way ANOVA followed by Sidak’s test p > 0.05. For panel (F), the number of animals was n = 211 to 234 from 10 independent
experiments. (E,F) Mean ± SEM.
as previously observed for several GOF alleles in a context of
memory (Pagani et al., 2009). However, even when CSW plays
a role in different organs or tissues (Figure 3), GOF csw only
produced a significant effect on life span when it was expressed
in the fat body (Figure 6). This defines a clear difference between
CSW normal functions and GOF CSW effects. Hence, it is
possible that the LOF csw allele, in contrast to the GOF allele,
produced a genetic dosage-dependent effect. Alternatively, the
LOF csw may be acting as the NSML-associated alleles, which
produce some phenotype owing to the loss of the PTP catalytic
action, whereas other phenotypes, such as the loss of an anti-
apoptotic effect, depended on the C-SH2 domain, which is PTP
and ERK1/2 independent (Stewart et al., 2010).
In addition, we did not detect an effect of LOF CSW at the
levels of pERK or pAKT compared with the control genotype
(Supplementary Figure S2), whereas reduced pAKT levels were
detected at the posterior midgut, and no pERK was detected
in the same gut region (Figures 2D–F and Supplementary
Figure S3). These observations suggested that the average
amount of pAKT and pERK was similar in LOF CSW and
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FIGURE 6 | Gain-of-function (GOF) csw T73I allele in fat body, but not wild-type (WT) csw allele, reduced life span. (A,B) Effect of overexpressing WT csw in fat body
at 25◦C (A) and at 29◦C (B). Note survival early in life at 25◦C of the FB/cswWT compared with parental lines (FB/+ and cswWT/+) (p > 0.05). (C–G) Effect of GOF
csw-T73I transgene targeted to specific tissues on life span. (C) Survival curves after overexpressing GOF csw-T73I to all cells of fruit flies by a weak driver
(Armadillo-GAL4) compared with parental genotypes (p > 0.05). (D) Survival curves showing the effect of overexpressing GOF csw-T73I driven to neurons by a
specific GAL4 driver (elav;csw-T73I) and parental lines (+;csw-T73I and elav;+) (p > 0.05). (E) Overexpressing GOF csw-T73I in muscle by a specific GAL4 driver
(DJ757;csw-T73I) compared with parental lines (+;csw-T73I and DJ757;+) (p > 0.05). (F,G) Survival curves of flies overexpressing GOF csw-T73I in fat body by a
specific GAL4 driver (FB; csw-T73I) and parental lines (+;csw-T73I and FB;+) in experiments performed at 25◦C (F) or at 29◦C (G). Note that GOF csw-T73I
significantly reduced survival at 25◦C, whereas at 29◦C, a non-significant tendency in early life up to 40 days old is shown. Log-rank test, corrected for multiple
comparisons for all panels and Wilcoxon test in panel (A,F,G). Number of animals was n = 86 to 134 at least from four independent experiments.
control genotype, at least when a mix of all tissues of the body
was analyzed. This might be possible if the intensity and the
time course of signaling activity would be dissimilar in different
tissues, and some differences in a specific tissue might be diluted
on the average. A dissimilar activity can be expected because
the CSW expression levels differ substantially in different tissues
(Graveley et al., 2011). Also, AKT but not ERK was activated by
refeeding in the gut, at least after 16 h of fasting followed by
4 h of refeeding (Figures 2D–F). In the same line of thought,
when we examined pAKT by immunostaining, we found a clear
pAKT staining with 4 h of refeeding in the posterior midgut, but
not in more anterior regions of the gut. Therefore, these data
suggested that the activity of AKT and ERK after refeeding will
take place at different times in different organs of the body and
even within the same organ.
More important, regardless of the levels of pAKT, the
LOF csw allele impaired the localization of pAKT in plasma
membrane and in the nucleus (Figure 2F), which might be
even more significant to disrupt an effective signal transduction
than the total levels of activated AKT. Consequently, it is
possible to expect that some effects of the manipulations of
csw might depend not necessarily on the levels of phospho-
proteins but on the impaired sub-cellular localization or in
the time course of signaling transduction, as we previously
showed for pERK in the fly head after olfactory conditioning
(Pagani et al., 2009).
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FIGURE 7 | Schematic representation of potential CSW-dependent mechanisms for life span regulation. CSW-mediated life span modulation depending on organs
regulating energy resources acquired by feeding, like gut, fat body, and neurons. Arrows between them indicate subsequent effects. Through the insulin-like growth
factor signaling (IIS) pathway, CSW in fat body and neurons produced systemic effect on all peripheral tissues such as metabolic homeostasis and aging delay.
Likely, CSW acting in gut mediates IIS pathway-dependent local effects (see Figure 3E). Different tissues are not equally sensitive to loss-of-function (LOF) and
gain-of-function (GOF) csw alleles.
CSW and the Insulin-Like Growth Factor
Signaling Pathway
It was previously established that SHP2 participates as a
molecular component downstream of InRs; however, its role on
metabolism and survival was obscure. In this study, we identified
that the PTP CSW controls life span through modulation of
the IIS pathway (Figures 1, 2) (Tatar et al., 2001). This effect
appeared to be mediated by systemic positive and negative
regulatory roles on survival by acting in the fat body, which
in turn may affect IPCs and the Dilp2-dependent peripheral
tissues (Figures 3–6) (Géminard et al., 2009; Rajan and Perrimon,
2012). This interpretation supports a key role of the IIS pathway
in fat body, as well as a systemic effect of fat body, which is
consistent with the current understanding of fat body in the
regulation of metabolism (Colombani et al., 2003; Géminard
et al., 2009; Rajan and Perrimon, 2012; Wang et al., 2014).
Comparably, transgenic mice expressing a dominant-negative
form of SHP2 showed insulin resistance in muscle and adipocytes
(Maegawa et al., 1999), whereas tissue-specific reduction of
SHP2 function in hepatocytes or adipocytes showed increased
tolerance to insulin and high-fat diets (Matsuo et al., 2010;
Nagata et al., 2012). Consistently, systemic and local insulin-
dependent modulation was reported (Wang et al., 2014). In this
regard, whereas suppressing CSW function in neurons or the fat
body increased median life span, it did not affect maximum life
span (Figures 3A–C). However, suppressing CSW function in
the gut increased maximum life span but not median life span
(Figure 3E). This suggested that csw operates differently in the
gut (e.g., by a local effect) whereas, in the fat body or neurons, it is
expected to regulate life span through a systemic effect (Figure 7).
We did not provide direct evidence that the reduced life span
in CSW GOF was mediated by IIS pathway. Yet a number of
observations provide a clear possibility. First, csw LOF prolongs
life span by interacting with InRE19 and chico1 and impairs
the activation and localization of pAKT, suggesting that IIS is
involved in the effects of CSW on life span. Additionally, CSW
prolonged life span in poor and rich diets and increased TG levels
like insulin signaling mutants. Finally, when we examined which
tissues might be involved in CSW LOF effects, we found that csw-
RNAi in fat body reduced life span, supporting the idea that IIS
is involved in the effects of CSW on life span. Altogether, these
data indicated that IIS might be involved in the effect of CSW
GOF on life span.
However, we found that by overexpressing the GOF csw
allele T73I in fat body, life span was strongly reduced at 25◦C,
whereas at 29◦C, only a small but not significant tendency was
detected in early life (Figures 6F,G). Consistently, a similar
tendency was observed in fruit flies overexpressing WT CSW
protein in fat body at 25◦C compared with 29◦C (Figures 6A,B).
Therefore, in GOF and WT transgenic flies, a reduced survival
in early life appeared more evident at 25◦C. This result did not
depend on a thermosensitive GOF or WT CSW proteins with
reduced activity at 29◦C because these proteins are functional
at 30◦C, producing a specific effect in long-term memory
(Pagani et al., 2009), as well as at 29◦C, producing lethality
in the case of GOF protein expressed in the whole body (see
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section “Overexpression of Gain-of-Function csw in the Fat Body
Reduced Life Span”).
One possible explanation for the effect of GOF CSW at
25◦C, but not at 29◦C, is that this protein in fat body shows a
genotype× environment interaction. A more complex possibility
is that the dynamics of the GOF CSW protein at 29◦C becomes
functionally more like its interacting proteins (i.e., CHICO, PI3K,
and RAS) (Figure 2A). The dynamics of activation of the GOF
CSW protein is faster than the WT protein (Keilhack et al.,
2005), but GOF and WT transgenes produced a faster signaling
activation than the endogenous CSW protein (Pagani et al., 2009).
Moreover, the molecular dynamics of WT proteins is expected
to be faster at 29◦C than at 25◦C (i.e., Q10 of 2–3 for most
enzymes). Thus, in a condition where the molecular dynamics
of all cells is speeded up by temperature at 29◦C, the enhanced
activity of GOF CSW protein may become more compatible
to the molecular context, reducing the severity of the life span
impairment. This idea implies that the activity of the GOF CSW
protein is proportionally less affected by temperature than its
interacting WT proteins. Such condition perhaps can be achieved
because T73I GOF CSW has shifted the basal equilibrium state
toward the active state (i.e., ∼10-fold higher basal activity than
the WT CSW protein) but appear to be∼4-fold less responsive to
stimulation than the WT CSW protein because it is almost at the
top activity in the basal state (Keilhack et al., 2005).
CSW and Metabolic Rate Homeostasis
During Activity
We found that the control genotype showed a constant average
metabolic rate at different levels of activity (Figures 5C,D).
In contrast, LOF csw mutants showed a significant regression
of metabolic rate over activity index (Figures 5C,D). This
observation suggested that CSW contributes to the maintenance
of a constant metabolism because it was lost with LOF
CSW. Because we performed these experiments in fruit flies
fed ad libitum, it is expected that they consume mainly
carbohydrates, and, therefore, the relation between CO2
production and O2 utilization, or RQ, would be equal to 1 in
both genotypes (Wang et al., 2008). Therefore, a larger CO2
production cannot be explained by an altered RQ; even if the LOF
csw flies use more fat or proteins as their energy resource, RQ
will be reduced by increased oxygen consumption (Wang et al.,
2008). However, an RQ above 1 has been reported in patients with
overfeeding, which may explain an enhanced CO2 production
(Hulst et al., 2005). Levels of energy consumption during activity
can vastly exceed the levels required at rest. For instance,
Drosophila in flight require up to 70-fold more oxygen than at
rest (Wegener, 1996). However, this cannot explain the observed
differences because there was no change in activity within age
group in respirometry or in climbing assays throughout life
(Figure 5), suggesting that other mechanisms might be involved.
In fact, it was reported that the GOF csw allele E76K increases
oxygen consumption, mitochondrial respiratory function, and
reactive oxygen species (ROS) generation (Zheng et al., 2013).
Although CO2 production was not analyzed in that report, it
is feasible that the LOF csw allele also affects mitochondrial
function underlying the effect reported here (Figures 5C,D). In
fact, oxygen consumption rate is higher in mitochondria of SHP2
knock-out liver cells (Nagata et al., 2012), although the reason
for our observation on metabolic rate remains unclear, strongly
indicating a loss of metabolic homeostasis in the LOF csw fruit
flies, supporting its role in metabolism.
Taken together, our experiments showed that manipulations of
CSW in Drosophila can be used to study the relationship between
organs in metabolism as well as its role in NS throughout adult
life. This establishes a solid base to study in detail the effect of
mutations modeling NS and NSML in fruit flies, which will allow
us to learn about these disorders and insulin functions as well.
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